In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...
Equities research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Pfizer in a report released ...
Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...
With a market cap of $144.8 billion, New York ... Pfizer raised its full-year revenue guidance to $61 billion - $64 billion and adjusted EPS guidance to $2.75 - $2.95. However, the stock fell ...
Pfizer Inc. (NYSE:PFE – Get Free Report) saw unusually large options trading activity on Thursday. Traders acquired 251,131 ...
Pfizer's stock experienced a notable decline on Friday at the New York Stock Exchange, falling 1.6% to $26.03 per share following news of a $59.7 million settlement payment. The settlement stems from ...
Citi analyst Geoff Meacham maintained a Hold rating on Pfizer (PFE – Research Report) today. The company’s shares closed yesterday at ...
Taking full advantage of the stock market and investing with confidence ... favorable times to buy high-momentum stocks. New York-based Pfizer markets a wide range of drugs and vaccines.